Ergoteles’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,094
Closed -$530K 949
2023
Q2
$530K Buy
42,094
+19,932
+90% +$242K 0.03% 628
2023
Q1
$289K Sell
22,162
-89,067
-80% -$1.44M 0.01% 911
2022
Q4
$1.96M Buy
111,229
+45,413
+69% +$761K 0.07% 285
2022
Q3
$1M Buy
65,816
+36,429
+124% +$589K 0.04% 480
2022
Q2
$436K Buy
29,387
+8,789
+43% +$164K 0.01% 900
2022
Q1
$464K Buy
+20,598
New +$417K 0.02% 682
2021
Q4
Sell
-70,400
Closed -$941K 1683
2021
Q3
$941K Sell
70,400
-1,333
-2% -$21.5K 0.03% 395
2021
Q2
$1.33M Buy
71,733
+34,185
+91% +$575K 0.03% 439
2021
Q1
$564K Sell
37,548
-17,523
-32% -$281K 0.02% 464
2020
Q4
$795K Buy
55,071
+42,671
+344% +$516K 0.03% 369
2020
Q3
$101K Buy
+12,400
New +$101K 0.01% 536

Other funds holding MDRX

Ergoteles's MDRX Position: Q3 2023 in Review

Ergoteles sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2023, closing a stake of 42,094 shares — an estimated $530K sold.

Ergoteles first reported a position in MDRX in Q3 2020 and held it in 11 quarters. The position peaked at $1.96M in Q4 2022. 216 funds tracked by Wall St. Rank hold MDRX as of Q3 2023.

  • Ergoteles reported no remaining Veradigm Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 42,094 Veradigm Inc. Common Stock shares in Q3 2023, an estimated $530K.
  • Ergoteles first reported a position in Veradigm Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Ergoteles's Veradigm Inc. Common Stock position peaked at $1.96M in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.